Medtronic

Recent news

• Rating change
  William Blair Maintains Medtronic(MDT.US) With Buy Rating
  Market Newswire · 2026/9/11
• Rating change
  A Quick Look at Today's Ratings for Medtronic(MDT.US), With a Forecast Between $95 to $115
  Market Newswire · 2026/9/3
• Company notice
  Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Walter Matthew R.
  SEC · 2026/7/10
• TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110
  Market Newswire · 2026/9/30
• Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
  PR Newswire · 2026/9/14
• Company notice
  Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Blomquist Denise L.
  SEC · 2026/9/17
• Rating change
  Citi Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110
  Market Newswire · 2026/9/10
• Company notice
  Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Walter Matthew R.
  SEC · 2026/6/9
• Company notice
  Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Walter Matthew R.
  SEC · 2026/5/29
• Rating change
  Wells Fargo Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $104
  Market Newswire · 2026/9/10
• BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110
  Market Newswire · 2026/9/14
• Rating change
  Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)
  TipRanks · 2026/9/2
• UBS Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $110
  Market Newswire · 2026/9/3
• Needham Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $114
  Market Newswire · 2026/9/17
• Company notice
  Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Blomquist Denise L.
  SEC · 2026/6/9
• Rating change
  J.P. Morgan Maintains Medtronic(MDT.US) With Hold Rating, Raises Target Price to $96
  Market Newswire · 2026/9/4
• Rating change
  TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $110
  Market Newswire · 2026/8/28
• Rating change
  A Quick Look at Today's Ratings for Medtronic(MDT.US), With a Forecast Between $95 to $118
  Market Newswire · 2026/9/2
• Rating change
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Fortrea Holdings Inc. (FTRE), Medtronic (MDT) and Immunic (IMUX)
  TipRanks · 2026/9/2
• Rating change
  Needham Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $114
  Market Newswire · 2026/8/27
• Medtronic shares rise against the market trend as it launches the MiniMed spin-off via share exchange.
  Zhitong Finance · 9/14
• TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110
  Market Newswire · 9/15
• Press Release: Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
  Dow Jones · 9/14
• Company notice
  Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Wall Brett A.
  SEC · 5/29
• BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110
  Market Newswire · 9/8

Headlines are aggregated automatically and are not independently verified or edited by our team.